The Cardiometabolic Research (CMR) Therapeutic Area of Eli Lilly and Company focuses on the discovery of biologic, small molecule and genetic therapeutics for the treatment of cardiometabolic diseases and associated complications. The successful candidate will be responsible for supporting the data, tools and infrastructure that are critical for enabling clinical research objectives that will inform and accelerate the discovery and development of our next generation therapeutics. Specifically, we are seeking a key multi-dimensional individual to integrate and analyze genomic, proteomic, metabolomic and phenotypic data from publicly available biobank and proprietary data sets on cloud based clinical multi-omics platforms. We are seeking a Statistical Geneticist with expertise in whole genome sequencing (WGS), proteomics, and clinical outcomes analysis to advance our research in identifying novel therapeutic targets. This role will involve analyzing large-scale biobank and population-cohort datasets to uncover genetic and molecular factors associated with disease risk, progression, and treatment response. You will operate as part of the CMR Data Science and Computational Biology (DSCB) team and partner with early discovery scientists and clinicians, translational scientists, bioinformaticians and geneticists.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree